Stockreport

Viridian Therapeutics: Disconnect Between Fundamentals And Share Price In 2023 [Seeking Alpha]

Immunovant, Inc.  (IMVT) 
PDF Negative biotech sentiment was partly to blame, as well as Tepezza's Y/Y net sales declines, and some internal turmoil with two CEO changes. These events overshadowed [Read more]